![Dr Carl Counsell Dr Carl Counsell](/img/200x200/staffpages/uploads/mmd528/Carl_Counsell_ID.jpg)
MRCP, MSc, MD
Reader (Clinical)
- About
-
- Email Address
- carl.counsell@abdn.ac.uk
- Office Address
Room 1:009, Polwarth Building Division of Applied Health Sciences University of Aberdeen Foresterhill Aberdeen AB25 2ZD
- School/Department
- School of Medicine, Medical Sciences and Nutrition
Biography
Carl is a clinical reader and honorary consultant in neurology. He graduated in medicine from Cambridge University in 1988, did his early postgraduate medical training in London, Newcastle and Falkirk and then trained in neurology, stroke and epidemiology in Edinburgh. He spent a year in Melbourne where he specialised in movement disorders before taking up his present post in 2001. He is married to Gay, a GP, and has one daughter, Helena. A committed Christian, he would like to have more time to serve in his church and develop his interests in Fairtrade and conservation.
Latest Publications
Accuracy of routinely collected hospital administrative discharge data and death certificate ICD-10 diagnostic coding in progressive supranuclear palsy and corticobasal syndrome: a systematic review and validation study
Journal of Neurology, vol. 271, pp. 2929-2937Contributions to Journals: ArticlesTotal Patient Delay: A comparison of patient and clinician/health system delays in the diagnosis of progressive supranuclear palsy and corticobasal syndrome
Movement Disorders Clinical Practice, vol. 11, no. 5, pp. 478-487Contributions to Journals: ArticlesIncidence and risk factors of institutionalisation in Parkinson's disease and atypical parkinsonism
Parkinsonism & Related Disorders, vol. 118Contributions to Journals: ArticlesProgressive multifocal leukoencephalopathy associated with carbamazepine -: induced immune dysfunction and recovery after carbamazepine cessation
BMJ Case Reports, vol. 16, no. 7, e255119Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1136/bcr-2023-255119
- [ONLINE] View publication in Scopus
The evolution of diagnosis from symptom onset to death in progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) compared to Parkinson’s disease (PD)
Journal of Neurology, vol. 270, pp. 3464-3474Contributions to Journals: Articles
- Research
-
Research Overview
Carl is a consultant neurologist with subspecialty interest in movement disorders. His main research interests are in evidence-based medicine and broader aspects of clinical epidemiology such as incidence and prognostic studies, particularly in relation to Parkinson's disease, other movement disorders and stroke. His team have established several cohorts of parkinsonian patients for long-term follow-up and support a number of non-industry sponsored clinical trials and Cochrane reviews, whilst also trying to promote multidisciplinary neurology research in Aberdeen.
Research Areas
Accepting PhDs
I am currently accepting PhDs in Nutrition and Health.
Please get in touch if you would like to discuss your research ideas further.
Nutrition and Health
Accepting PhDsResearch Specialisms
- Clinical Medicine
Our research specialisms are based on the Higher Education Classification of Subjects (HECoS) which is HESA open data, published under the Creative Commons Attribution 4.0 International licence.
Current Research
The PINE study: a population-based incidence cohort of people with Parkinson's disease and other parkinsonian disorders, along with their carers and controls who are being followed up lifelong to establish long-term prognosis.
The Parkinson's Incidence Cohorts Collaboration: an individual patient data meta-analysis of all population- based incidence cohorts of Parkinson's disease to assess prognosis and allow prognostic modelling.
The Scottish PSP/CBD prevalence cohort: a cohort of people with two related Parkinson's plus disorders, Progressive Supranuclear Palsy and Corticobasal Degeneration as well as Parkinson's disease controls, to assess diagnostic and care pathways and prognosis.
Past Research
Cochrane systematic reviews of randomised trials in stroke care
Prognostic modelling in acute stroke
Incidence of Parkinson's disease and other parkinsonian disorders in North-East Scotland
Prevalence of multiple sclerosis in North-East Scotland and northern isles
Randomised trial of physiotherapy for cervical dystonia
Knowledge Exchange
Member of Parkinson's Excellence Network
Collaborations
Cochrane Collaboration Stroke Review Group, Professors Charles Warlow and Peter Sandercock, University of Edinburgh, UK, 1993-98.
Scottish Audit of Intracranial Vascular Malformations, Professor Rustam Al-Shahi Salman, University of Edinburgh, UK, 2002-2014.
PDMED trial, Professor Carl Clarke, University of Birmingham, UK, 2004-2020.
Clinical trial methods in neurodegenerative diseases, Professor John Zajicek, University of Plymouth, UK, 2009-2014.
PDCOMM trial, Professor Sackley, University of Nottingham, UK, 2016-2023.
NICE technology appraisals for multiple sclerosis, Universities of Warwick and Exeter, UK, 2016-2022
Parkinson's Incidence Cohorts Collaboration, Professor Tysnes, Dr Guido Alves, Professor Lars Forsgren, Dr Caroline Williams-Gray, Dr Alison Yarnall, Universities of Stavanger (Norway), Umea (Sweden), Cambridge (UK) and Newcastle (UK), 2018 ongoing
PD Connect exercise trial, Julie Jones, Robert Gordon University, Aberdeen, UK, 2019-2022
Supervision
Dr Kate Taylor (MD), 2002-06, Incidence and prognosis of parkinsonism in north-east Scotland: a pilot study.
Clare Harris (MSc), 2006-08, PINE participants attitudes to brain donation.
Dr Robert Caslake (PhD), 2006-11, Incidence and short-term porgnosis of Parkinson's disease andother parkinsonian disorders in north-east Scotland.
Dr Elizabeth Visser (MD), 2009-13, Prevalence of multiple sclerosis in northern Scotland.
Dr David McGhee (PhD), 2009-13, Improving clinical trial design in neurodegenerative diseases.
Dr Angus Macleod (PhD), 2012-15, Predicting mortality and dependency in Parkinson's disease.
Dr Diane Swallow (PhD), 2016-21, Assessing diagnostic pathways in progressive supranuclear palsy and corticobasal degeneration.
Funding and Grants
Research funding has been obtained from:
Parkinson’s UK, Scottish Chief Scientist Office, BMA Doris Hillier award, RS Macdonald Trust, BUPA Foundation, NHS Grampian endowments, Dystonia Society, National Institute for Health Research.
- Teaching
-
Teaching Responsibilities
Lectures and clinical teaching of neurology for medical and dental students.
Supervising medical student elective and MSc projects
Non-course Teaching Responsibilities
Regent to medical students
- Publications
-
Page 8 of 8 Results 176 to 191 of 191
Antiplatelet therapy for acute ischaemic stroke (updated Cochrane Review)
Cochrane Database of Systematic Reviews, no. 2Contributions to Journals: ArticlesHow to understand it:meta-analysis
Practical Neurology, vol. 3, no. 5, pp. 300-305Contributions to Journals: EditorialsLow-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischemic stroke (Cochrane review)
Stroke, vol. 33, no. 7, pp. 1925-1926Contributions to Journals: Review articles- [ONLINE] DOI: https://doi.org/10.1161/01.STR.0000018820.99077.46
Predicting outcome after acute and subacute stroke: development and validation of new prognostic models
Stroke, vol. 33, no. 4, pp. 1041-1047Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1161/hs0402.105909
Anticoagulants for preventing recurrence following acute ischaemic stroke or transient ischaemic attack
Cerebrovascular Diseases, vol. 13, no. Suppl 3Contributions to Journals: ArticlesAssessment of facial expression production in Parkinson’s disease
Perception, vol. 31Contributions to Journals: ArticlesCollaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
British Medical Journal, vol. 324, pp. 71-86Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1136/bmj.324.7329.71
Fibrinogen depleting agents for acute ischemic stroke
Cerebrovascular Diseases, vol. 13, no. Suppl 3Contributions to Journals: AbstractsImproving the quality, number and progress of randomised control trials
Clinical Trials. Duley, L., Farrell, B. (eds.). BMJ Publishing, pp. 57-71, 14 pagesChapters in Books, Reports and Conference Proceedings: ChaptersMe and my neurological illness: Beware the tilted pelvis
Practical Neurology, vol. 2, pp. 232-233Contributions to Specialist Publications: Letters- [ONLINE] DOI: https://doi.org/10.1046/j.1474-7766.2002.00075.x
Neuroprotection and Natural History in Parkinson Plus Syndromes (NNIPPS): design and progress of a clinical trial of the efficacy and safety of in Progressive Supranuclear Palsy (PSP) and Multiple System Atrophy (MSA)
Movement Disorders, vol. 17, no. SUPPL 5Contributions to Journals: ArticlesPrediction of outcome after stroke
The Lancet, vol. 358, no. 9292, pp. 1553Contributions to Journals: Letters- [ONLINE] DOI: https://doi.org/10.1016/S0140-6736(01)06607-7
Systematic Review of Prognostic Models in Patients with Acute Stroke
Cerebrovascular Diseases, vol. 12, no. 3, pp. 159-170Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1159/000047699
Reporting of randomised controlled trials
The Lancet, vol. 358, no. 9281, pp. 585Contributions to Journals: Letters- [ONLINE] DOI: https://doi.org/10.1016/S0140-6736(01)05727-0
Factors that limit the number, progress and quality of randomised controlled trials: a systematic review
The Advanced Handbook of Methods in Evidence Based Healthcare. Stevens, A., Abrams, K., Brazier, J., Fitzpatrick, R., Lifford, R. (eds.). Sage Publications, pp. 38-55, 17 pagesChapters in Books, Reports and Conference Proceedings: ChaptersBarriers to participation in randomised controlled trials: A systematic review
Journal of Clinical Epidemiology, vol. 52, no. 12, pp. 1143-1156Contributions to Journals: Literature Reviews